MiR-1231 decrease the risk of cancer-related mortality in patients combined with non-small cell lung cancer and diabetes mellitus

BACKGROUND: Non-small cell lung cancer (NSCLC) is a deadly human malignancy, and previous studies support the contribution of microRNAs (miRNAs) to cancer assessment. It has been reported that miR-1231 can be used as a biomarker to assess prognosis in different cancers. However, the prognostic value...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing, Xu, Jialiang, Cao, Zhijun, Du, Shouzuo, Zhang, Luyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487554/
https://www.ncbi.nlm.nih.gov/pubmed/32939184
http://dx.doi.org/10.1186/s12935-020-01525-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487554/
https://www.ncbi.nlm.nih.gov/pubmed/32939184
http://dx.doi.org/10.1186/s12935-020-01525-z

Ejemplares similares